Literature DB >> 23250465

[Antihyperglycaemic therapy in critically ill patients].

Martin Clodi1, Michael Resl, Heidemarie Abrahamian, Bernhard Föger, Raimund Weitgasser.   

Abstract

Hyperglycemia frequently occurs in critically ill patients resulting in major complications like an increased cardiovascular event rate or an increased incidence of infections. Based on the currently available evidence insulin therapy should be initiated in patients with blood glucose levels above 180 mg/dl. Blood glucose values should be maintained between 180 and 140 mg/dl. In surgical patients lower target values ranging from 140 to 110 mg/dl should be applied. After transition to the general ward a complete workup of diabetes mellitus should be performed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23250465     DOI: 10.1007/s00508-012-0281-3

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  7 in total

1.  Standards of medical care in diabetes--2011.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

2.  Intensive versus conventional glucose control in critically ill patients.

Authors:  Simon Finfer; Dean R Chittock; Steve Yu-Shuo Su; Deborah Blair; Denise Foster; Vinay Dhingra; Rinaldo Bellomo; Deborah Cook; Peter Dodek; William R Henderson; Paul C Hébert; Stephane Heritier; Daren K Heyland; Colin McArthur; Ellen McDonald; Imogen Mitchell; John A Myburgh; Robyn Norton; Julie Potter; Bruce G Robinson; Juan J Ronco
Journal:  N Engl J Med       Date:  2009-03-24       Impact factor: 91.245

3.  Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Linda L Humphrey; Roger Chou; Vincenza Snow; Paul Shekelle
Journal:  Ann Intern Med       Date:  2011-02-15       Impact factor: 25.391

Review 4.  Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data.

Authors:  Donald E G Griesdale; Russell J de Souza; Rob M van Dam; Daren K Heyland; Deborah J Cook; Atul Malhotra; Rupinder Dhaliwal; William R Henderson; Dean R Chittock; Simon Finfer; Daniel Talmor
Journal:  CMAJ       Date:  2009-03-24       Impact factor: 8.262

5.  Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.

Authors:  Renda Soylemez Wiener; Daniel C Wiener; Robin J Larson
Journal:  JAMA       Date:  2008-08-27       Impact factor: 56.272

Review 6.  Insulin therapy for the critically ill patient.

Authors:  Greet Van den Berghe
Journal:  Clin Cornerstone       Date:  2003

Review 7.  Insulin therapy in critically ill patients.

Authors:  Samer Ellahham
Journal:  Vasc Health Risk Manag       Date:  2010-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.